Mercaptopropionic Acid

Mercaptopropionic Acid

SCHEMBL436192

CCC.O=C(O)CCS.O=C(O)CCS.O=C(O)CCS

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 1/20 0.57
FFAR3 O14843 2/20 0.53
HDAC3 O15379 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC2 Q92769 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
FOLH1 Q04609 1/20 0.52
LMNA P02545 1/20 0.47
ALKBH5 Q6P6C2 1/20 0.47
SUCNR1 Q9BXA5 1/20 0.47
EGLN1 Q9GZT9 1/20 0.47
AKR1B1 P15121 1/20 0.46
KMT2A Q03164 2/20 0.44
MAPT P10636 1/20 0.44
GPR84 Q9NQS5 7/20 0.43
PPARG P37231 6/20 0.43
PPARD Q03181 6/20 0.43
PPARA Q07869 6/20 0.43
HDAC11 Q96DB2 5/20 0.43
TSHR P16473 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mercaptopropionic Acid SCHEMBL5424483 1.00 ACE (0.57) ACEFFAR3HDAC3HDAC1HDAC2
Mercaptopropionic Acid SCHEMBL28066151 0.94
Mercaptopropionic Acid SCHEMBL28405529 0.91 FFAR3 (0.59) ACEFFAR3HDAC3HDAC1HDAC2
Mercaptopropionic Acid SCHEMBL22471706 0.91 FFAR3 (0.59) ACEFFAR3HDAC3HDAC1HDAC2
Mercaptopropionic Acid SCHEMBL8724601 0.91 FFAR3 (0.58) ACEFFAR3HDAC3HDAC1HDAC2
Mercaptopropionic Acid SCHEMBL970738 0.91 FFAR3 (0.58) ACEFFAR3HDAC3HDAC1HDAC2
Mercaptopropionic Acid SCHEMBL5477406 0.91
Mercaptopropionic Acid SCHEMBL7779538 0.91 FFAR3 (0.59) ACEFFAR3HDAC3HDAC1HDAC2
Mercaptopropionic Acid SCHEMBL23499850 0.90 ACE (0.60) ACEFFAR3HDAC3HDAC1HDAC2
Mercaptopropionic Acid SCHEMBL10853644 0.90 ACE (0.67) ACEFFAR3HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1877839-A2 THERMOSETTING POLY(THIO)URETHANE FORMULATION COMPRISING AT LEAST ONE BLOCK COPOLYMER AND USE THEREOF IN OPTICS FOR THE PRODUCTION OF ORGANIC LENSES HAVING IMPROVED TOUGHNESS ESSILOR INTERNATIONAL Compagnie Générale d'Optique (FR) 2008-01-16 EP claimed
WO-2006103371-A2 THERMOSETTING POLY(THIO)URETHANE FORMULATION COMPRISING AT LEAST ONE BLOCK COPOLYMER AND USE THEREOF IN OPTICS FOR THE PRODUCTION OF ORGANIC LENSES HAVING IMPROVED TOUGHNESS ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2006-10-05 WO claimed
US-12006382-B2 (Meth)acrylate, monomer composition for dental material, molded body, composition for dental material, dental material, and method of manufacturing (meth)acrylate MITSUI CHEMICALS, INC. (JP) 2024-06-11 US disclosed
US-11958998-B2 Compositions, quantum dot polymer composites prepared therefrom, and devices including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-04-16 US disclosed
EP-3683629-B1 DEVELOPER CARRIER, PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS CANON KK (JP) 2023-04-12 EP disclosed
US-20210246239-A1 (METH)ACRYLATE, MONOMER COMPOSITION FOR DENTAL MATERIAL, MOLDED BODY, COMPOSITION FOR DENTAL MATERIAL, DENTAL MATERIAL, AND METHOD OF MANUFACTURING (METH)ACRYLATE MITSUI CHEMICALS, INC. (JP) 2021-08-12 US disclosed
EP-3795597-A1 (METH)ACRYLATE, MONOMER COMPOSITION FOR DENTAL MATERIAL, MOLDED BODY, COMPOSITION FOR DENTAL MATERIAL, DENTAL MATERIAL, AND METHOD FOR PRODUCING (METH)ACRYLATE Mitsui Chemicals, Inc. (JP) 2021-03-24 EP disclosed
US-10831125-B2 Developer carrying member, process cartridge, and electrophotographic apparatus CANON KABUSHIKI KAISHA (JP) 2020-11-10 US disclosed
EP-3683629-A1 DEVELOPER CARRIER, PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS C/o Canon Kabushiki Kaisha (JP) 2020-07-22 EP disclosed
US-20200201203-A1 DEVELOPER CARRYING MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS CANON KABUSHIKI KAISHA (JP) 2020-06-25 US disclosed
WO-2018157116-A1 OPTICAL FIBER COATING COMPOSITION NUFERN (US) 2018-08-30 WO disclosed
US-20110257454-A1 Use of an Additive in the Coupling of Toluene with a Carbon Source FINA TECHNOLOGY, INC. (US) 2011-10-20 US disclosed
US-20110255211-A1 HIGHLY DIELECTRIC FILM DAIKIN INDUSTRIES, LTD. (JP) 2011-10-20 US disclosed
WO-2010148424-A1 THIOURETHANE-BASED LENS ELEMENTS AND PROCESSES FOR THEIR PRODUCTION CARL ZEISS VISION AUSTRALIA HOLDINGS LIMITED (AU) 2010-12-29 WO disclosed
EP-1877839-A2 THERMOSETTING POLY(THIO)URETHANE FORMULATION COMPRISING AT LEAST ONE BLOCK COPOLYMER AND USE THEREOF IN OPTICS FOR THE PRODUCTION OF ORGANIC LENSES HAVING IMPROVED TOUGHNESS ESSILOR INTERNATIONAL Compagnie Générale d'Optique (FR) 2008-01-16 EP disclosed
US-20070286968-A1 Compound, liquid crystal composition, and their applications FUJIFILM CORPORATION (JP) 2007-12-13 US disclosed
WO-2006103371-A2 THERMOSETTING POLY(THIO)URETHANE FORMULATION COMPRISING AT LEAST ONE BLOCK COPOLYMER AND USE THEREOF IN OPTICS FOR THE PRODUCTION OF ORGANIC LENSES HAVING IMPROVED TOUGHNESS ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2006-10-05 WO disclosed
US-5019483-A Aqueous developable photoresist containing weak alkali soluble or dispersible thiol compounds 501 INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 1991-05-28 US disclosed
US-4766201-A Hydroxy alkyl amide thio ether composition from bis-bicyclic amide acetal and polythiol ASHLAND OIL INC. (US) 1988-08-23 US disclosed
US-4665229-A Preparation of hydroxy alkyl amide thio ether compounds from bicyclic amide acetal and thiol ASHLAND OIL, INC. (US) 1987-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12006382-B2 (Meth)acrylate, monomer composition for dental material, molded body, composition for dental material, dental material, and method of manufacturing (meth)acrylate MMAB, ACR, MAT2B ACE 4566/4885FFAR3 1735/4885HDAC3 3445/4885
US-20210246239-A1 (METH)ACRYLATE, MONOMER COMPOSITION FOR DENTAL MATERIAL, MOLDED BODY, COMPOSITION FOR DENTAL MATERIAL, DENTAL MATERIAL, AND METHOD OF MANUFACTURING (METH)ACRYLATE MMAB, ACR, MAT2B ACE 4566/4885FFAR3 1735/4885HDAC3 3445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.